Activities of Manogepix and Comparators against 1,435 Recent Fungal Isolates Collected during an International Surveillance Program (2020)
Michael A. Pfaller, Michael D. Huband, Paul R. Rhomberg, Paul Bien, Mariana Castanheira
Abstract
We evaluated the in vitro activity of manogepix and comparator agents against 1,435 contemporary fungal isolates collected worldwide from 73 medical centers in North America, Europe, the Asia-Pacific region, and Latin America during 2020. Of the isolates tested, 74.7% were Candida spp.; 3.7% were non- Candida yeasts, including 27 Cryptococcus neoformans var. grubii (1.9%); 17.1% were Aspergillus spp.; and 4.5% were other molds.
Topics & Concepts
Cryptococcus neoformansBiologyCryptococcosisCryptococcusMicrobiologyAspergillusAntifungal resistance and susceptibilityFungal Infections and StudiesNail Diseases and Treatments